EUVIMEDEUVIMED entdecken
Crossref

MOF‐Coated Upconversion Nanoparticle Agents Enable Synergistic Photodynamic Therapy and Immunotherapy

Jiarui Du, Tao Jia, Feng Li, Yang Li, Qinghui Wang, Liangcan He, Hans Ågren, Guanying Chen

Advanced Functional Materials · 2024-09 · 34 (36)

DOI: 10.1002/adfm.202401272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 03.04.2024. Verfasst von Jiarui Du und 7 weiteren Autor:innen. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although conventional therapeutic approaches demonstrate significant success in treating primary tumors, their efficacy diminishes when addressing distant and metastatic tumors, calling for new technologies to transport and activate the therapeutic agents. Here, a core‐shell UCNP@MOF (upconversion nanoparticle — metal organic framework) nanoagents is constructed for Type I and Type II photodynamic therapy under biocompatible near‐infrared light irradiance (at 808 nm) and utilize their pore loading capacity to further realize synergistic immunotherapy in solid tumors. The Cu 2+ to Cu + reduction at the nodes in the MOFs shell is demonstrated to promote the generation of reactive oxygen species via depletion of overexpressed glutathione (GSH) compounds, while tumor microenvironment‐enriched hydrogen peroxide is found to substantially augment the PDT effects. Importantly, the MOFs pore‐loaded indoleamine 2,3‐dioxygenase (IDO) inhibitor, along with s‐nitroso‐n‐acetylpenicillamine (SNAP), upregulated tumor‐infiltrating lymphocytes and induced prominent immunotherapeutic effects in vivo. This core‐shell UCNP@MOF nanoagents have demonstrated effectiveness against both primary and distant tumors in xenografted tumor models, holding promise for treating solid tumors in metastasis.

Förderung

  • Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Du, J., Jia, T., Li, F., Li, Y., Wang, Q., He, L., Ågren, H., & Chen, G. (2024). MOF‐Coated Upconversion Nanoparticle Agents Enable Synergistic Photodynamic Therapy and Immunotherapy. Advanced Functional Materials, 34(36). https://doi.org/10.1002/adfm.202401272

Vancouver

Du J, Jia T, Li F, Li Y, Wang Q, He L, et al. MOF‐Coated Upconversion Nanoparticle Agents Enable Synergistic Photodynamic Therapy and Immunotherapy. Advanced Functional Materials. 2024;34(36). doi:10.1002/adfm.202401272

BibTeX
@article{Du2024,
  author = {Du, Jiarui and Jia, Tao and Li, Feng and Li, Yang and Wang, Qinghui and He, Liangcan and Ågren, Hans and Chen, Guanying},
  title = {MOF‐Coated Upconversion Nanoparticle Agents Enable Synergistic Photodynamic Therapy and Immunotherapy},
  journal = {Advanced Functional Materials},
  year = {2024},
  volume = {34},
  number = {36},
  doi = {10.1002/adfm.202401272}
}
Kostenlos starten →